Metformin modulates microbiota and improves blood pressure and cardiac remodeling in a rat model of hypertension

Here are the Metformin modulates microbiota and improves blood pressure and cardiac remodeling in a rat model of hypertension journals presenting the latest research across various disciplines. From social sciences to technology, each article is expected to provide valuable insights to our readers.

Metformin modulates microbiota and improvest, metformin modulates microbiota and improves memory, metformin modulates and demodulates, metformin modulates microbiota and improves crossword, metformin modulates synonym, metformin modulates microbiota and cancer, metformin modulates microbiota and improves antonym, metformin modulates microbiota plant, metformin modulates meaning.

Metformin modulates microbiota and improves blood pressure and cardiac remodeling in a rat model of hypertension

Aims: Metformin has been attributed to cardiovascular protection even in the absence of diabetes. Recent observations suggest that metformin influences the gut microbiome. We aimed to investigate the influence of metformin on the gut microbiota and hypertensive target organ damage in hypertensive rats.

Methods: Male double transgenic rats overexpressing the human renin and angiotensinogen genes (dTGR), a model of angiotensin II-dependent hypertension, were treated with metformin (300 mg/kg/day) or vehicle from 4 to 7 weeks of age. We assessed gut microbiome composition and function using shotgun metagenomic sequencing and measured blood pressure via radiotelemetry. Cardiac and renal organ damage and inflammation were evaluated by echocardiography, histology, and flow cytometry.

Results: Metformin treatment increased the production of short-chain fatty acids (SCFA) acetate and propionate in feces without altering microbial compos ition and diversity. It significantly reduced systolic and diastolic blood pressure and improved cardiac function, as measured by end-diastolic volume, E/A, and stroke volume despite increased cardiac hypertrophy. Metformin reduced cardiac inflammation by lowering macrophage infiltration and shifting macrophage subpopulations towards a less inflammatory phenotype. The observed improvements in blood pressure, cardiac function, and inflammation correlated with fecal SCFA levels in dTGR. In vitro, acetate and propionate altered M1-like gene expression in macrophages, reinforcing anti-inflammatory effects. Metformin did not affect hypertensive renal damage or microvascular structure.

Conclusion: Metformin modulated the gut microbiome, increased SCFA production, and ameliorated blood pressure and cardiac remodeling in dTGR. Our findings confirm the protective effects of metformin in the absence of diabetes, highlighting SCFA as a potential mediators. © 2024 The Author(s). Acta Physiologica published by John Wiley & Sons Ltd on behalf of Scandinavian Physiological Society.

Authors : Wimmer M.I.; Bartolomaeus H.; Anandakumar H.; Chen C.-Y.; Vecera V.; Kedziora S.; Kamboj S.; Schumacher F.; Pals S.; Rauch A.; Meisel J.; Potapenko O.; Yarritu A.; Bartolomaeus T.U.P.; Samaan M.; Thiele A.; Stürzbecher L.; Geisberger S.Y.; Kleuser B.; Oefner P.J.; Haase N.; Löber U.; Gronwald W.; Forslund-Startceva S.K.; Müller D.N.; Wilck N.

Source : John Wiley and Sons Inc